Most not too long ago, it has been discovered that conolidine and the above mentioned derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in similar areas as classical opioid receptors, it binds to a big range of endogenous opioids. As opposed to most opioid receptors, this receptor https://richardu714gdy3.vidublog.com/profile